LRMR icon

Larimar Therapeutics
LRMR

Overview Fund Activity

57 hedge funds and large institutions have $206M invested in Larimar Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 2 closing their positions.

Holders
57
Holders Change
+14
Holders Change %
+32.56%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
16
Increased
10
Reduced
15
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
1
Ikarian Capital
Texas
$6.22M
2
Millennium Management
2
Millennium Management
New York
$5.17M
3
CCM
3
CAAS Capital Management
New York
$3.2M
4
Verition Fund Management
4
Verition Fund Management
Connecticut
$3.35M
5
SFM
5
Sphera Funds Management
Israel
$1.46M

Top Sellers

1
ACP
1
Acuta Capital Partners
California
$0
2
LGM
2
Logos Global Management
California
$3.36M
3
O
3
OrbiMed
New York
$9.02M
4
JGC
4
J. Goldman & Co
New York
$167K
5
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$163K
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$10K 710 -1,225 -63%
Group One Trading
52
Group One Trading
Illinois
$6K 416 – –
PCM
53
Penserra Capital Management
California
$5K 350 -5 -1%
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$1K 91 -17 -16%
ACP
55
Acuta Capital Partners
California
– – -863,100 Closed
Wells Fargo
56
Wells Fargo
California
– – -5,604 Closed
UBS Group
57
UBS Group
Switzerland
$0 8 -291 -97%
Daiwa Securities Group
58
Daiwa Securities Group
Japan
$0 29 – –
CFGS
59
Concourse Financial Group Securities
Alabama
– – – –
JPMorgan Chase & Co
60
JPMorgan Chase & Co
New York
$0 12 – –
1 2
3